Harnessing Genetic Data for Drug Success

A significant scale of genetic data, reaching close to a million individuals, positioned the company as a leader in creating the largest consented genetic database globally. This vast collection enabled the pursuit of ambitious research goals aimed at drug discovery, showing that drugs with a genomic foundation had a success rate two to three times higher than those without. The existing challenge in the biotech industry, where studies often rely on limited animal data and face recruitment difficulties, highlighted the exceptional value of this genetic library for pharmaceutical companies in developing new therapeutics through strategic partnerships.